Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

Fear of blindness in the Collaborative Initial Glaucoma Treatment Study: patterns and correlates over time.

Janz NK, Wren PA, Guire KE, Musch DC, Gillespie BW, Lichter PR; Collaborative Initial Glaucoma Treatment Study..

Ophthalmology. 2007 Dec;114(12):2213-20.

PMID:
17490746
2.

Ranibizumab and pegaptanib for the treatment of age-related macular degeneration: a systematic review and economic evaluation.

Colquitt JL, Jones J, Tan SC, Takeda A, Clegg AJ, Price A.

Health Technol Assess. 2008 May;12(16):iii-iv, ix-201. Review.

3.

[Relevance of quality of life and treatment compliance measurement in patients with chronic open-angle glaucoma].

Baudouin C, Béchetoille A, Bron A, Denis P, Nordmann JP, Renard JP, Rouland JF, Sellem E, Rigeade MC, Arnould B.

J Fr Ophtalmol. 2000 Dec;23(10):1057-64. Review. French.

5.

The glaucomas.

Coleman AL, Brigatti L.

Minerva Med. 2001 Oct;92(5):365-79. Review.

PMID:
11675580
6.

Evaluation of quality of life for patients with glaucoma.

Spaeth G, Walt J, Keener J.

Am J Ophthalmol. 2006 Jan;141(1 Suppl):S3-14. Review.

PMID:
16389055
7.

Health related quality of life instruments for glaucoma: a comprehensive review.

Tripop S, Pratheepawanit N, Asawaphureekorn S, Anutangkoon W, Inthayung S.

J Med Assoc Thai. 2005 Nov;88 Suppl 9:S155-62. Review.

PMID:
16681070
8.

A review of the choice of therapy in primary open angle glaucoma.

Omoti AE.

Niger J Clin Pract. 2005 Jun;8(1):29-34. Review.

PMID:
16392453
9.

Quality of life assessment in blindness prevention interventions.

Ellwein LB, Fletcher A, Negrel AD, Thulasiraj RD.

Int Ophthalmol. 1994-1995;18(5):263-8. Review.

PMID:
7607806
10.

Risk and risk factors for blindness from glaucoma.

Chen PP.

Curr Opin Ophthalmol. 2004 Apr;15(2):107-11. Review.

PMID:
15021221
11.

Glaucoma in oman: a review.

Khandekarl R, Zutshi R.

J Glaucoma. 2006 Jun;15(3):271-3. Review.

PMID:
16778653
12.

Economic impact of primary open-angle glaucoma in Australia.

Dirani M, Crowston JG, Taylor PS, Moore PT, Rogers S, Pezzullo ML, Keeffe JE, Taylor HR.

Clin Exp Ophthalmol. 2011 Sep-Oct;39(7):623-32. doi: 10.1111/j.1442-9071.2011.02530.x. Review.

PMID:
21631669
13.

The management of primary open angle glaucoma.

[No authors listed]

Drug Ther Bull. 1997 Jan;35(1):4-6. Review.

PMID:
9282410
14.

Ethnic differences in glaucoma: prevalence, management, and outcome.

Wadhwa SD, Higginbotham EJ.

Curr Opin Ophthalmol. 2005 Apr;16(2):101-6. Review.

PMID:
15744140
15.

Risk assessment in the management of patients with ocular hypertension.

Weinreb RN, Friedman DS, Fechtner RD, Cioffi GA, Coleman AL, Girkin CA, Liebmann JM, Singh K, Wilson MR, Wilson R, Kannel WB.

Am J Ophthalmol. 2004 Sep;138(3):458-67. Review.

PMID:
15364230
16.

[Quality of life in glaucoma patients].

Jurowska-Liput J, Niźankowska MH.

Klin Oczna. 2005;107(10-12):707-9. Review. Polish.

PMID:
16619826
17.

Primary open angle glaucoma. The need for a consensus case definition.

Kroese M, Burton H.

J Epidemiol Community Health. 2003 Sep;57(9):752-4. Review.

18.

Clinical management of glaucoma.

King A, Migdal C.

J R Soc Med. 2000 Apr;93(4):175-7. Review. No abstract available.

19.

[The diagnosis and treatment of glaucoma].

Vesti E.

Duodecim. 1995;111(11):1059-62. Review. Finnish. No abstract available.

PMID:
9081845
20.

[Inflammatory glaucomas].

Grüb M, Deuter CM, Zierhut M.

Klin Monbl Augenheilkd. 2005 Oct;222(10):783-7. Review. German.

PMID:
16240270
Items per page

Supplemental Content

Support Center